Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Sorin receives CE mark approval for Memo 3D ReChord

Italy-based medical device company Sorin Group has received CE mark approval for its new mitral valve annuloplasty ring, Memo 3D ReChord.

Sorin

Memo 3D ReChord is the repair device, which was developed to deliver better patient outcomes while facilitating the surgical procedure.

Sorin Group cardiac surgery business unit president Michel Darnaud said: "Memo 3D ReChord is the latest result of our continuous effort to bring innovation to cardiac surgery teams. It represents a great opportunity to advance our presence in the mitral valve repair market.

"It has been engineered to fulfill the growing demand for faster and more reproducible artificial chord replacement. We are committed to setting high standards in design and performance to support patients and cardiac surgeons in the management of mitral valve disease."

Featuring chordal guiding system, the Memo 3D ReChord makes artificial chordae tendineae replacement a routine and standardized procedure.

In addition, the system features Carbofilm coating and laser cut Ni-Ti Ni-Ti technology, which improves physiologic performance.

Sorin develops and markets medical technologies for cardiac surgery, as well as for the treatment of cardiac rhythm disorders.


Image: Memo 3D Rechord annuloplasty ring. Photo: courtesy of Business Wire.